• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过HindIII限制性片段长度多态性分析揭示的人类补体C4A无效等位基因(C4A Q0)结构基础的异质性。

Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.

作者信息

Uring-Lambert B, Vegnaduzzi N, Carroll M C, Tongio M M, Goetz J, Hauptmann G

出版信息

FEBS Lett. 1987 Jun 8;217(1):65-8. doi: 10.1016/0014-5793(87)81244-9.

DOI:10.1016/0014-5793(87)81244-9
PMID:2885219
Abstract

The highly polymorphic fourth component of human complement (C4) is usually encoded by two genes. C4A and C4B, adjacent to the 21-hydroxylase (21-OH) genes, 21-OHA and 21-OHB, and is also remarkable in the high frequency of the 'null' alleles, C4A Q0 and C4B Q0. The molecular basis for the C4A Q0 allele was studied in 26 families through restriction fragment length polymorphism (RFLP) analysis with C4 and 21-OH cDNA probes after digestion of the DNA with the endonuclease HindIII. The individuals expressing the extended haplotype HLA-A1 (of A2) Cw7 B8 C2C BfS C4AQ0B1 DR3 have a large deletion taking off the C4A and 21-OHA genes.

摘要

人类补体的高度多态性第四成分(C4)通常由两个基因编码。C4A和C4B,与21-羟化酶(21-OH)基因21-OHA和21-OHB相邻,并且“无效”等位基因C4A Q0和C4B Q0的频率也很高。通过用核酸内切酶HindIII消化DNA后,用C4和21-OH cDNA探针进行限制性片段长度多态性(RFLP)分析,在26个家系中研究了C4A Q0等位基因的分子基础。表达扩展单倍型HLA-A1(A2型)Cw7 B8 C2C BfS C4AQ0B1 DR3的个体存在一个大的缺失,该缺失去除了C4A和21-OHA基因。

相似文献

1
Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.通过HindIII限制性片段长度多态性分析揭示的人类补体C4A无效等位基因(C4A Q0)结构基础的异质性。
FEBS Lett. 1987 Jun 8;217(1):65-8. doi: 10.1016/0014-5793(87)81244-9.
2
Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.系统性硬化症中补体第二和第四成分及其基因的分子异质性,以及HLA等位基因A1、B8与局限性系统性硬化症的关联,HLA等位基因DR5与弥漫性系统性硬化症的关联。
Exp Clin Immunogenet. 1998;15(2):90-9. doi: 10.1159/000019059.
3
Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus.系统性红斑狼疮中补体成分C4基因缺失与21-羟化酶基因的分子异质性
Arthritis Rheum. 1988 Jun;31(6):736-44. doi: 10.1002/art.1780310606.
4
C4A gene deletion: association with Graves' disease.C4A基因缺失:与格雷夫斯病的关联
J Mol Endocrinol. 1989 Sep;3(2):145-53. doi: 10.1677/jme.0.0030145.
5
Molecular basis of complete C4 deficiency. A study of three patients.完全性C4缺乏的分子基础。对三名患者的研究。
Hum Immunol. 1989 Feb;24(2):125-32. doi: 10.1016/0198-8859(89)90052-9.
6
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.人类补体C4和类固醇21-羟化酶基因的多态性。揭示结构缺失、同型重复和大小变异的限制性片段长度多态性。
J Clin Invest. 1986 Sep;78(3):650-7. doi: 10.1172/JCI112623.
7
DNA polymorphism of human HLA-linked complement C4 allotypes, including C4 null alleles, in the Finnish population.芬兰人群中人类HLA连锁补体C4同种异型包括C4无效等位基因的DNA多态性。
Hum Hered. 1987;37(4):241-9. doi: 10.1159/000153711.
8
Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.一名患有额顶部线状硬皮病的患者及其家族中补体第四成分(C4)和第二成分(C2)存在不完全功能缺陷。缺陷由一个与人类白细胞抗原系统不连锁的基因决定。
Exp Clin Immunogenet. 1996;13(2):104-11.
9
Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.I型糖尿病、格雷夫斯病和桥本甲状腺炎中的III类等位基因及高危MHC单倍型。
Mol Biol Med. 1986 Apr;3(2):143-57.
10
Inherited deficiency of the fourth component of human complement.人类补体第四成分的遗传性缺陷。
Immunodefic Rev. 1988;1(1):3-22.

引用本文的文献

1
Repurposing Kinase Inhibitor Bay 11-7085 to Combat and Biofilms.重新利用激酶抑制剂Bay 11-7085来对抗生物膜。
Front Pharmacol. 2021 May 5;12:675300. doi: 10.3389/fphar.2021.675300. eCollection 2021.
2
Complement C4 and heat shock protein 70 (HSP70) genotypes and type I diabetes mellitus.
Immunogenetics. 1990;32(6):427-30. doi: 10.1007/BF00241637.
3
Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes.γ干扰素和内毒素对人C4基因表达的反向调节作用。
J Clin Invest. 1990 Mar;85(3):943-9. doi: 10.1172/JCI114523.